Objective: To investigate the acceptability of the Cytosponge, a novel sampling device to detect Barrett's oesophagus (BE), a precursor to oesophageal adenocarcinoma (EAC), among people with risk factors for this condition. Design: A qualitative study using semistructured interviews and focus group discussions. Data were explored by three researchers using thematic analysis. Setting: Community setting in London, UK. Participants: A recruitment company identified 33 adults (17 men, 16 women) aged 50–69 years with gastro-oesophageal reflux disease (GERD), a risk factor for BE. The majority of participants were white British (73%). The focus groups were stratified by gender and education. 10 individuals were interviewed and 23 participated in ...
Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocar...
The landscape for patients with Barrett's oesophagus (BE) has changed significantly in the last deca...
Objective To assess health-related quality of life in patients with non-dysplastic Barrett’s oesopha...
Cancer Research UK programme grant (C8162/A16892). Smith is supported by a Cancer Research UK Post...
Objectives: The BEST3 trial demonstrated the efficacy and safety of the Cytosponge-trefoil factor 3,...
BACKGROUND & AIMS: Diagnosis and surveillance of Barrett's esophagus (BE) and eosinophilic esophagit...
BACKGROUND: Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; how...
Background: Early detection of oesophageal cancer improves outcomes; however, the optimal strategy f...
BACKGROUND: Early detection of oesophageal cancer improves outcomes; however, the optimal strategy f...
BACKGROUND: Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophag...
Abstract Background The Cytosponge is a cell-collection device, which, coupled with a test for trefo...
Background: Esophageal adenocarcinoma (EAC) accounts for an estimated 15 690 deaths in the US each y...
BACKGROUND: Barrett's oesophagus predisposes to adenocarcinoma. However, most patients with Barrett'...
This multicentre, pragmatic, randomised controlled trial was done in 109 socio-demographically diver...
Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocar...
Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocar...
The landscape for patients with Barrett's oesophagus (BE) has changed significantly in the last deca...
Objective To assess health-related quality of life in patients with non-dysplastic Barrett’s oesopha...
Cancer Research UK programme grant (C8162/A16892). Smith is supported by a Cancer Research UK Post...
Objectives: The BEST3 trial demonstrated the efficacy and safety of the Cytosponge-trefoil factor 3,...
BACKGROUND & AIMS: Diagnosis and surveillance of Barrett's esophagus (BE) and eosinophilic esophagit...
BACKGROUND: Treatment of dysplastic Barrett's oesophagus prevents progression to adenocarcinoma; how...
Background: Early detection of oesophageal cancer improves outcomes; however, the optimal strategy f...
BACKGROUND: Early detection of oesophageal cancer improves outcomes; however, the optimal strategy f...
BACKGROUND: Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophag...
Abstract Background The Cytosponge is a cell-collection device, which, coupled with a test for trefo...
Background: Esophageal adenocarcinoma (EAC) accounts for an estimated 15 690 deaths in the US each y...
BACKGROUND: Barrett's oesophagus predisposes to adenocarcinoma. However, most patients with Barrett'...
This multicentre, pragmatic, randomised controlled trial was done in 109 socio-demographically diver...
Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocar...
Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocar...
The landscape for patients with Barrett's oesophagus (BE) has changed significantly in the last deca...
Objective To assess health-related quality of life in patients with non-dysplastic Barrett’s oesopha...